Bardo, M., Neisewander, J., & Ennis, R. (1988). Chronic treatment with naltrexone enhances morphine-stimulated dopamine neurotransmission: neurochemical and behavioral evidence. Neuropharmacology, 27(11), 1103-9. https://doi.org/10.1016/0028-3908(88)90004-4

Cheung, T., Nolan, B., Hammerslag, L., Weber, S., Durbin, J., Peartree, N., … Neisewander, J. (2012). Phenylpiperazine derivatives with selectivity for dopamine D3 receptors modulate cocaine self-administration in rats. Neuropharmacology, 63(8), 1346-59. https://doi.org/10.1016/j.neuropharm.2012.08.011

Nolan, B., Liu, S., Hammerslag, L., Cheung, T., Lenz, J., Mach, R., … Neisewander, J. (2013). Fos expression in response to dopamine D3-preferring phenylpiperazine drugs given with and without cocaine. Synapse (New York, N.Y.), 67(12), 847-55. https://doi.org/10.1002/syn.21691

Bardo, M., Neisewander, J., & Kelly, T. (2013). Individual differences and social influences on the neurobehavioral pharmacology of abused drugs. Pharmacological Reviews, 65(1), 255-90. https://doi.org/10.1124/pr.111.005124

Bardo, M., Miller, J., & Neisewander, J. (1984). Conditioned place preference with morphine: the effect of extinction training on the reinforcing CR. Pharmacology, Biochemistry, and Behavior, 21(4), 545-9. https://doi.org/10.1016/s0091-3057(84)80037-4

Bardo, M., Neisewander, J., & Miller, J. Repeated testing attenuates conditioned place preference with cocaine. Psychopharmacology, 89(2), 239-43. https://doi.org/10.1007/BF00310636 (Original work published 1986)

Bardo, M., & Neisewander, J. (1986). Single-trial conditioned place preference using intravenous morphine. Pharmacology, Biochemistry, and Behavior, 25(5), 1101-5. https://doi.org/10.1016/0091-3057(86)90092-4

Neisewander, J., & Bardo, M. Expression of morphine-conditioned hyperactivity is attenuated by naloxone and pimozide. Psychopharmacology, 93(3), 314-9. https://doi.org/10.1007/BF00187249 (Original work published 1987)

Bardo, M., & Neisewander, J. (1987). Chronic naltrexone supersensitizes the reinforcing and locomotor-activating effects of morphine. Pharmacology, Biochemistry, and Behavior, 28(2), 267-73. https://doi.org/10.1016/0091-3057(87)90224-3

Neisewander, J., Nonneman, A., Rowlett, J., & Bardo, M. (1969). Impaired supersensitivity to morphine following chronic naltrexone treatment in senescent rats. Neurobiology of Aging, 15(1), 91-7. https://doi.org/10.1016/0197-4580(94)90148-1 (Original work published 1969)